This announcement is a separate document:
杭州天目山药业股份有限公司关于公司未来三年（2023年2025年）股东分红回报规划
Hangzhou Tianmushan Pharmaceutical Co., Ltd.\'s shareholder dividend return plan for the next three years (2023-2025)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.